A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

The results of the present study show that systemic inflammation-based scores, in particular the mGPS and PI, have prognostic value in cancer independent of tumour site. Based on the present results and the existing validation literature, the mGPS should be included in the routine assessment of all patients with cancer.